These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1371169)

  • 21. Identification of Mengo virus T helper cell epitopes.
    Muir S; Kobasa D; Bittle J; Scraba D
    J Gen Virol; 1994 Nov; 75 ( Pt 11)():2925-36. PubMed ID: 7525861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of rubella virus-neutralising antibodies by vaccination with synthetic peptides.
    Robinson K; Mostratos A; Grencis RK
    FEMS Immunol Med Microbiol; 1995 Feb; 10(3-4):191-8. PubMed ID: 7539669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polyvalent synthetic vaccines: relationship between T epitopes and immunogenicity.
    Jolivet M; Lise L; Gras-Masse H; Tartar A; Audibert F; Chedid L
    Vaccine; 1990 Feb; 8(1):35-40. PubMed ID: 1690488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction.
    Lairmore MD; DiGeorge AM; Conrad SF; Trevino AV; Lal RB; Kaumaya PT
    J Virol; 1995 Oct; 69(10):6077-89. PubMed ID: 7545241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The identification of immunodominant linear epitopes of dengue type 2 virus capsid and NS4a proteins using pin-bound peptides.
    Anandarao R; Swaminathan S; Khanna N
    Virus Res; 2005 Sep; 112(1-2):60-8. PubMed ID: 16022901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and immunological characterization of a 134-mer synthetic peptide corresponding to the N-terminal half of the HIV-1 nucleoprotein, p24.
    Chong P; Sia C; Tam E; Kandil A; Klein M
    Int J Pept Protein Res; 1993 Jan; 41(1):21-7. PubMed ID: 7679666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mapping of linear B cell epitopes on capsid proteins of bovine papillomavirus: identification of three external type-restricted epitopes.
    Cason J; Kambo PK; Jewers RJ; Chrystie IL; Best JM
    J Gen Virol; 1993 Dec; 74 ( Pt 12)():2669-77. PubMed ID: 8277272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mimicry of viral epitopes with retro-inverso peptides of increased stability.
    Benkirane N; Guichard G; Briand JP; Muller S; Brown F; Van Regenmortel MH
    Dev Biol Stand; 1996; 87():283-91. PubMed ID: 8854029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A universal T cell epitope-containing peptide from hepatitis B surface antigen can enhance antibody specific for HIV gp120.
    Greenstein JL; Schad VC; Goodwin WH; Brauer AB; Bollinger BK; Chin RD; Kuo MC
    J Immunol; 1992 Jun; 148(12):3970-7. PubMed ID: 1376346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 10-amino-acid linear sequence of VP1 of foot and mouth disease virus containing B- and T-cell epitopes induces protection in mice.
    Zamorano P; Wigdorovitz A; Perez-Filgueira M; Carrillo C; Escribano JM; Sadir AM; Borca MV
    Virology; 1995 Oct; 212(2):614-21. PubMed ID: 7571431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigenic sequences of poliovirus recognized by T cells: serotype-specific epitopes on VP1 and VP3 and cross-reactive epitopes on VP4 defined by using CD4+ T-cell clones.
    Mahon BP; Katrak K; Mills KH
    J Virol; 1992 Dec; 66(12):7012-20. PubMed ID: 1279196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of antibody response to the measles virus using synthetic peptides of the fusion protein. Evidence of non-random pairing of T and B cell epitopes.
    Muller CP; Handtmann D; Brons NH; Weinmann M; Wiesmüller KH; Spahn G; Wiesneth M; Schneider F; Jung G
    Virus Res; 1993 Dec; 30(3):271-80. PubMed ID: 8109160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study of antibody and T cell responses in rabbits immunized with synthetic human B cell epitope analogues of La (SSB) autoantigen.
    Yiannaki E; Vlachoyiannopoulos PG; Manoussakis MN; Sakarellos C; Sakarellos-Daitsiotis M; Moutsopoulos HM; Tzioufas AG
    Clin Exp Immunol; 2000 Sep; 121(3):551-6. PubMed ID: 10971524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.
    Callebaut I; Vonèche V; Mager A; Fumière O; Krchnak V; Merza M; Zavada J; Mammerickx M; Burny A; Portetelle D
    J Virol; 1993 Sep; 67(9):5321-7. PubMed ID: 7688821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B synthetic immunogen comprised of nucleocapsid T-cell sites and an envelope B-cell epitope.
    Milich DR; Hughes JL; McLachlan A; Thornton GB; Moriarty A
    Proc Natl Acad Sci U S A; 1988 Mar; 85(5):1610-4. PubMed ID: 2449694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of orientation and number of copies of T and B cell epitopes on the specificity and affinity of antibodies induced by chimeric peptides.
    Partidos C; Stanley C; Steward M
    Eur J Immunol; 1992 Oct; 22(10):2675-80. PubMed ID: 1382995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunization with a peptide having both T cell and conformationally restricted B cell epitopes elicits neutralizing antisera against a snake neurotoxin.
    Léonetti M; Pillet L; Maillère B; Lamthanh H; Frachon P; Couderc J; Ménez A
    J Immunol; 1990 Dec; 145(12):4214-21. PubMed ID: 1701784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity of the human immunodeficiency virus (HIV) recombinant nef gene product. Mapping of T-cell and B-cell epitopes in immunized chimpanzees.
    Bahraoui E; Yagello M; Billaud JN; Sabatier JM; Guy B; Muchmore E; Girard M; Gluckman JC
    AIDS Res Hum Retroviruses; 1990 Sep; 6(9):1087-98. PubMed ID: 1702299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mapping an antibody-binding site and a T-cell-stimulating site on the 1A protein of respiratory syncytial virus.
    Nicholas JA; Mitchell MA; Levely ME; Rubino KL; Kinner JH; Harn NK; Smith CW
    J Virol; 1988 Dec; 62(12):4465-73. PubMed ID: 2460636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccine engineering: enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T- and B-cell epitopes.
    Tam JP; Lu YA
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9084-8. PubMed ID: 2480595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.